Dr. Raymond Thertulien M.D.
Hematologist-Oncologist | Hematology & Oncology
20 Medical Park Dr Asheville NC, 28803Rating
4/5
About
Dr. Raymond Thertulien is a hematologist oncologist practicing in Asheville, NC. Dr. Thertulien specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Provider Details
Clinical Trials
- Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
- Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
- Breast Cancer WEight Loss Study (BWEL Study)
- Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
- S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
- S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
- Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
- S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
- Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
- Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
- PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
- Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
- Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
- Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
- Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
- Cabozantinib S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
- Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
- Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
- Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
- Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Dr. Raymond Thertulien M.D.'s Practice location
Practice At 20 Medical Park Dr
20 Medical Park Dr -Asheville, NC 28803Get Direction
CHARLOTTE, NC 28204Get Direction
AdventHealth Infusion Center Weaverville
179 North Buncombe School Rd Ste 102 -Weaverville, NC 28787Get Direction
AdventHealth Infusion Center Hendersonville
50 Hospital Drive Ste 4B -Hendersonville, NC 28792Get Direction
Dr. Raymond Thertulien M.D.'s reviews
Write ReviewPatient Experience with Dr. Thertulien
Recommended Articles
![]()
Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a CauseEveryone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...
![]()
How Immunotherapy Makes a Real Difference in Relapsed Hodgkin LymphomaHodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
![]()
The Lymphoma Research Foundation's Light it Red for Lymphoma NightLymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
![]()
Superheroes Unite For Elementary Student Fighting LymphomaAnyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...
![]()
What Specialists Treat Multiple Myeloma?If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
![]()
'Sophie the Brave' Fights Childhood T-Cell LymphomaThe story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...
Nearby Providers
![]()
Dr. Martin Palmeri M.D.,M.B.A.21 HOSPITAL DR Asheville NC 28801![]()
Dr. Shonda Michelle Asaad M.D.20 Medical Park Dr. Asheville NC 28803![]()
Dr. Michael Joseph Messino M.D.445 Biltmore Ave Asheville NC 28801![]()
Dr. Mohan Chand Thakuri MD445 Biltmore Ave Asheville NC 28801![]()
Dr. Louay Hanna M.D.20 Medical Park Drive Asheville NC 28803![]()
Dr. William M Butler MD80 DOCTORS DR STE 1 HENDERSONVILLE NC 28792
Nearest Hospitals
PARK RIDGE HEALTHl
100 HOSPITAL DRIVE HENDERSONVILLE NC 28792MARGARET R PARDEE MEMORIAL HOSPITALl
800 N JUSTICE ST HENDERSONVILLE NC 28791MARGARET R PARDEE MEMORIAL HOSPITALl
800 N JUSTICE ST HENDERSONVILLE NC 28791PARK RIDGE HEALTHl
100 HOSPITAL DRIVE HENDERSONVILLE NC 28792